SDAM
Shulman DeMeo Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $228K | Hold |
2,751
| – | – | 0.06% | 105 |
|
2025
Q1 | $223K | Hold |
2,751
| – | – | 0.06% | 102 |
|
2024
Q4 | $248K | Hold |
2,751
| – | – | 0.07% | 103 |
|
2024
Q3 | $272K | Sell |
2,751
-839
| -23% | -$82.9K | 0.07% | 109 |
|
2024
Q2 | $333K | Buy |
3,590
+1
| +0% | +$93 | 0.09% | 92 |
|
2024
Q1 | $341K | Hold |
3,589
| – | – | 0.09% | 96 |
|
2023
Q4 | $320K | Hold |
3,589
| – | – | 0.09% | 95 |
|
2023
Q3 | $262K | Buy |
3,589
+838
| +30% | +$61.2K | 0.09% | 104 |
|
2023
Q2 | $229K | Sell |
2,751
-838
| -23% | -$69.7K | 0.07% | 113 |
|
2023
Q1 | $274K | Hold |
3,589
| – | – | 0.09% | 103 |
|
2022
Q4 | $298K | Hold |
3,589
| – | – | 0.1% | 100 |
|
2022
Q3 | $285K | Hold |
3,589
| – | – | 0.1% | 98 |
|
2022
Q2 | $267K | Sell |
3,589
-156
| -4% | -$11.6K | 0.09% | 108 |
|
2022
Q1 | $337K | Hold |
3,745
| – | – | 0.09% | 103 |
|
2021
Q4 | $419K | Buy |
+3,745
| New | +$419K | 0.11% | 89 |
|
2021
Q3 | – | Sell |
-3,745
| Closed | -$507K | – | 134 |
|
2021
Q2 | $507K | Hold |
3,745
| – | – | 0.2% | 31 |
|
2021
Q1 | $508K | Buy |
3,745
+838
| +29% | +$114K | 0.14% | 75 |
|
2020
Q4 | $409K | Sell |
2,907
-4,697
| -62% | -$661K | 0.12% | 85 |
|
2020
Q3 | $648K | Buy |
7,604
+4,853
| +176% | +$414K | 0.22% | 50 |
|
2020
Q2 | $308K | Hold |
2,751
| – | – | 0.12% | 80 |
|
2020
Q1 | $213K | Hold |
2,751
| – | – | 0.1% | 85 |
|
2019
Q4 | $262K | Hold |
2,751
| – | – | 0.09% | 106 |
|
2019
Q3 | $210K | Hold |
2,751
| – | – | 0.07% | 123 |
|
2019
Q2 | $241K | Hold |
2,751
| – | – | 0.09% | 111 |
|
2019
Q1 | $249K | Buy |
+2,751
| New | +$249K | 0.09% | 106 |
|